搜尋結果
Zealand Pharma Shares Jump 17% After Positive Trial Results For Ozempic Competitor
Forbes· 1 日前Shares for Zealand Pharma rose by over 17% on Friday, after the Danish biotech firm announced positive trial results for ...
Mounjaro Drug Tirzepatide Could Treat Sleep Apnea, Study Finds
Forbes· 1 日前Eli Lilly’s weight loss injection tirzepatide — the ingredient inside its wildly popular drugs Mounjaro and Zepbound — could ...
UFC Saudi Arabia: Whittaker vs. Aliskerov—Odds, Lines, Prop Bets And Picks
Forbes· 1 日前A look at the betting odds, prop bets. picks, and predictions for Saturday's UFC Saudi Arabia main card, the scheduled main ...
How Long Can Extreme Concentration Last?
Forbes· 1 日前It has been a good year for the large capitalization market averages. The S&P 500 is up about 14% so far this year. Furthermore ...
The 10 Best Performing Stocks So Far In 2024
Forbes· 1 日前The stocks have been on a tear with year-to-date gains ranging from 387% to more than a jaw-dropping 1,100% (as of June ...
Inside The Rubble Of Diddy’s Empire
Forbes· 1 日前All that is left of 1710 Broadway—a six-story building that began life in 1919 as a Ford Motor ...
Sara Duterte to ‘go on the offensive’ after break from Philippines’ Marcos
South China Morning Post· 1 日前The vice-president is set to pose a significant political challenge to Marcos, with surveys ...
Stronger health awareness awakens sleep economy
China Daily· 1 日前China's sleep economy is experiencing rapid growth as well as showing vast business potential, thanks to a consumption upgrade ...
Report says drug abuse in decline
China Daily· 1 日前While drug smuggling remains a challenge, drug abuse in China has continued to decline ...
US FDA approves expanded use of Sarepta's Duchenne gene therapy
Reuters· 1 日前, opens new tab gene therapy for all patients with Duchenne muscular dystrophy aged four and ...